Intelligent Bio Solutions Inc (INBS)
2.38
+0.04
(+1.71%)
USD |
NASDAQ |
May 16, 16:00
2.27
-0.11
(-4.62%)
After-Hours: 20:00
Intelligent Bio Solutions Enterprise Value: -1.595M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | -1.595M |
May 15, 2024 | -1.720M |
May 14, 2024 | -1.564M |
May 13, 2024 | -1.502M |
May 10, 2024 | -1.720M |
May 09, 2024 | -1.315M |
May 08, 2024 | -1.221M |
May 07, 2024 | -0.0055M |
May 06, 2024 | -1.284M |
May 03, 2024 | -1.555M |
May 02, 2024 | -1.263M |
May 01, 2024 | -1.292M |
April 30, 2024 | -1.176M |
April 29, 2024 | -0.8553M |
April 26, 2024 | -1.176M |
April 25, 2024 | -1.817M |
April 24, 2024 | -1.525M |
April 23, 2024 | -0.9135M |
April 22, 2024 | -1.263M |
April 19, 2024 | -1.030M |
April 18, 2024 | -0.8553M |
April 17, 2024 | -1.205M |
April 16, 2024 | -0.4474M |
April 15, 2024 | 0.485M |
April 12, 2024 | -0.156M |
Date | Value |
---|---|
April 11, 2024 | 0.7473M |
April 10, 2024 | 0.8347M |
April 09, 2024 | 1.534M |
April 08, 2024 | 1.942M |
April 05, 2024 | 2.233M |
April 04, 2024 | 1.942M |
April 03, 2024 | 2.088M |
April 02, 2024 | 2.408M |
April 01, 2024 | 2.816M |
March 31, 2024 | 3.282M |
March 28, 2024 | 11.36M |
March 27, 2024 | 12.01M |
March 26, 2024 | 11.50M |
March 25, 2024 | 11.44M |
March 22, 2024 | 10.36M |
March 21, 2024 | 9.795M |
March 20, 2024 | 11.22M |
March 19, 2024 | 11.30M |
March 18, 2024 | 11.30M |
March 15, 2024 | 11.84M |
March 14, 2024 | 12.09M |
March 13, 2024 | 12.41M |
March 12, 2024 | 12.58M |
March 11, 2024 | 9.200M |
March 08, 2024 | 9.330M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.850M
Minimum
Feb 22 2022
149.04M
Maximum
Dec 23 2020
13.38M
Average
3.969M
Median
Enterprise Value Benchmarks
Ainos Inc | 10.44M |
OpGen Inc | 13.31M |
Zomedica Corp | 97.64M |
LENSAR Inc | 29.50M |
Eargo Inc (DELISTED) | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.978M |
Revenue (Quarterly) | 0.8238M |
Total Expenses (Quarterly) | 3.778M |
EPS Diluted (Quarterly) | -1.43 |
Gross Profit Margin (Quarterly) | 21.67% |
Profit Margin (Quarterly) | -361.5% |
Earnings Yield | -2.59K% |
Normalized Earnings Yield | -2654.25 |